ReviewMultiple sclerosis (Houndmills, Basingstoke, England)2024

Selecting Informative Patients for Phase 2 Progressive Trials in MS: Design Considerations for Phase 2 Clinical Trials in Progressive MS.

Marcus W Koch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.